AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30409170
Drug: Daily mobilisation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily mobilisation in a tilt table with an integrated stepping device (ERIGO)
Trial: 26248565
Drug: Nondairy isocaloric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nondairy isocaloric and isoprotein supplement
Trial: 22878686
Drug: No injection
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No injection (Group C)
Trial: 16648324
Drug: Aripiprazole 15
RxNorm normalized name: aripiprazole 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole 15 mg/day
Trial: 17663105
Drug: Electroacupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture treatment group
Trial: 17663105
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (anti-infection, inhibiting secretion of pancreas, improving microcirculation, protective agent of gastric mucosa)
Trial: 11155965
Drug: TCAs plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCAs plus lithium, monoamine oxidase inhibitors (MAOIs), or electroconvulsive therapy (ECT)
Trial: 8923355
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human tumor necrosis factor receptor (p80) fusion protein (rhTNFR:Fc)
Trial: 28664388
Drug: Photobiomodulation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photobiomodulation therapy (PBM) from admission (AD) to D+7
Trial: 28664388
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (oral hygiene)
Trial: 23167783
Drug: Bromocriptine 2.5
RxNorm normalized name: bromocriptine 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine 2.5 mg daily for 14 days
Trial: 23167783
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 2.0 mg daily for 14 days (Control)
Trial: 14510929
Drug: Topiramate (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (50 mg daily after titration)
Trial: 1326721
Drug: Thymex L
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymex L (100 mg 3 times a week, total dose 1800 mg, i.m.)
Trial: 3919028
Drug: Placebo or
RxNorm normalized name: placebo ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo or no drug therapy (Control)
Trial: 29512827
Drug: 170 μg
RxNorm normalized name: dimethicone
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 170 μg LPP administered subcutaneously over 3 weeks
Trial: 24606070
Drug: Testosterone gel
RxNorm normalized name: Androgel 1.62% Metered Dose Pump Testosterone Gel
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone gel (high or low physiological dose)
Trial: 11372586
Drug: Napsagatran (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Napsagatran (80 micrograms/min) + Warfarin (25 mg)
Trial: 9732921
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg and amoxicillin 1 g, both given twice daily for 2 weeks (OA)
Trial: 9732921
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg once daily, clarithromycin 500 mg twice daily, and metronidazole 400 mg twice daily for 1 week (OCM)
Trial: 3141099
Drug: Insulin-glyburide combination
RxNorm normalized name: Glyburide
DrugBank: Glyburide (DB01016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-glyburide combination therapy
Trial: 28974203
Drug: Cefazolin administered
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefazolin administered prior to skin incision
Trial: 28974203
Drug: Cefazolin administered
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefazolin administered after cord clamping
Trial: 25846340
Drug: Faster-acting insulin
RxNorm normalized name: diphenhydramine
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Faster-acting insulin aspart
Trial: 20838775
Drug: DAMP (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAMP (20 mg/70 kg)
Trial: 12439626
Drug: Placebo Nefazodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo Nefazodone (0 mg/day)
Trial: 10856143
Drug: Salmeterol 50
RxNorm normalized name: FLUTICAS 100/SALMETEROL 50 INHL DISK 14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol 50 microg combined with fluticasone 100 microg (combination product)
Trial: 7974906
Drug: Cisplatin plus
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin plus ifosfamide (VIP, VeIP) and high-dose carboplatin and etoposide with AUBMT for poor-risk GCT patients
Trial: 7974906
Drug: Paclitaxel in
RxNorm normalized name: paclitaxel Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel in combination chemotherapy regimens
Trial: 17643436
Drug: PHOPDT (Photodynamic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PHOPDT (Photodynamic therapy with Photofrin)
Trial: 11999592
Drug: Combined sciatic-femoral
RxNorm normalized name: Sus scrofa temporal lobe preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined sciatic-femoral nerve block with 25 mL mepivacaine 2% (15 mL for femoral nerve, 10 mL for sciatic nerve)
Trial: 11999592
Drug: General anaesthetic
RxNorm normalized name: General anaesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anaesthetic with continuous intravenous infusion of remifentanil (0.1-0.3 microgkg(‐1) min(‐1)) and propofol (target plasma concentration 2-4 microg mL(‐1))
Trial: 9657355
Drug: Losartan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50 mg p.o.)
Trial: 9657355
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II (i.v. infusion for 60 min at doses of 4, 8, and 16 ng/kg/min)
Trial: 330302
Drug: Cholestyramine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestyramine (4 g, three times daily for 3 weeks)
Trial: 330302
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment (dietary restriction and ad libitum antacid)
Trial: 6119939
Drug: 0.05 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05 mg/kg of morphine (postoperative)
Trial: 6119939
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of pethidine (postoperative)
Trial: 6119939
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg of fentanyl (postoperative)
Trial: 6119939
Drug: 0.05 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05 mg/kg of morphine (peroperative)
Trial: 6119939
Drug: epidural injection
RxNorm normalized name: Sufentanil Citrate 50 ug in 1 mL EPIDURAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: epidural injection of morphine after neuroleptoanaesthesia
Trial: 17968815
Drug: Silymarin (280
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silymarin (280 mg administered 10 hours and 1.5 hours prior to nifedipine)
Trial: 17968815
Drug: Nifedipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (10 mg) alone
Trial: 21865319
Drug: Silymarin (280
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silymarin (280 mg)
Trial: 17968815
Drug: Nifedipine and
RxNorm normalized name: nifedipine and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine and silymarin co-administration
Trial: 15156430
Drug: Once-daily HAART
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily HAART
Trial: 15156430
Drug: Twice-daily HAART
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily HAART
Trial: 10553804
Drug: SS-cream 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SS-cream 0.05 g
Trial: 10553804
Drug: SS-cream 0.10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SS-cream 0.10 g
Trial: 10553804
Drug: SS-cream 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SS-cream 0.15 g
Trial: 10688090
Drug: SS-cream 0.20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SS-cream 0.20 g
Trial: 2119153
Drug: Alfentanil (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil (50 micrograms/kg IV bolus followed by infusion at 1 micrograms.kg‐1.min‐1)
Trial: 710268
Drug: Traditional supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional supportive therapy (TST)
Trial: 24089054
Drug: Sodium benzoate
RxNorm normalized name: Sodium Benzoate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium benzoate (1 g/d)
Trial: 19786674
Drug: Decision aid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decision aid for diabetes medication choice
Trial: 15246627
Drug: BEC2 anti-idiotypic
RxNorm normalized name: anti-CD11a
DrugBank: Efalizumab (DB00095)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: BEC2 anti-idiotypic monoclonal antibody vaccine (2.5 microg - 10 mg)
Trial: 15246627
Drug: BEC2 anti-idiotypic
RxNorm normalized name: anti-CD11a
DrugBank: Efalizumab (DB00095)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: BEC2 anti-idiotypic monoclonal antibody vaccine (lower three dose levels)
Trial: 15246627
Drug: BEC2 anti-idiotypic
RxNorm normalized name: anti-CD11a
DrugBank: Efalizumab (DB00095)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: BEC2 anti-idiotypic monoclonal antibody vaccine (high doses)
Trial: 12218721
Drug: Soy isoflavone
RxNorm normalized name: soy isoflavone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy isoflavone extract (70 mg genistin and daidzin per day)
Trial: 7619676
Drug: 5-hydroxy-L-tryptophan (5-HTP)
RxNorm normalized name: 5-hydroxy-L-tryptophan
DrugBank: Oxitriptan (DB02959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-hydroxy-L-tryptophan (5-HTP)
Trial: 362297
Drug: cyclophosphamide (additional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cyclophosphamide (additional treatment during second interval)
Trial: 30368163
Drug: MSI-195 800
RxNorm normalized name: morphine sulfate Oral Solution [MSIR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MSI-195 800 mg added to ongoing ADT
Trial: 23135172
Drug: Planned Treatment
RxNorm normalized name: Plan B One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Planned Treatment Interruption (PTI)
Trial: 16136947
Drug: Composite Xin
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Composite Xin Mai Tong (XMT) capsules
Trial: 12189365
Drug: Citalopram (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (20 mg to 40 mg once daily)
Trial: 8750400
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg twice daily for 3 days
Trial: 6110654
Drug: Lithium carbonate
RxNorm normalized name: Lithium Carbonate
DrugBank: Lithium carbonate (DB14509)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lithium carbonate added to neuroleptic treatment
Trial: 28978543
Drug: Cream cheese
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cream cheese
Trial: 27852706
Drug: AbobotulinumtoxinA (BoNT‐A)
RxNorm normalized name: abobotulinumtoxinA
DrugBank: Botulinum toxin type A (DB00083)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: AbobotulinumtoxinA (BoNT‐A) injection guided by electrostimulation
Trial: 27852706
Drug: AbobotulinumtoxinA (BoNT‐A)
RxNorm normalized name: abobotulinumtoxinA
DrugBank: Botulinum toxin type A (DB00083)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: AbobotulinumtoxinA (BoNT‐A) injection guided by ultrasound
Trial: 24468886
Drug: GCPGC at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GCPGC at 100 μg/kg
Trial: 24468886
Drug: GCPGC at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GCPGC at 30-100 μg/kg
Trial: 24468886
Drug: GCPGC at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GCPGC at 300 μg/kg
Trial: 24468886
Drug: Pegfilgrastim at
RxNorm normalized name: Pegfilgrastim
DrugBank: Pegfilgrastim (DB00019)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pegfilgrastim at 100 μg/kg
Trial: 22081256
Drug: Clopidogrel tapering
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel tapering (75 mg every other day for 4 weeks)
Trial: 18065578
Drug: Fish-oil capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish-oil capsules - 1-2 capsules per day
Trial: 16617852
Drug: Group 1
RxNorm normalized name: Chlamydophila psittaci biogroup 1 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 1 (blood sampling for hormone analysis)
Trial: 8688981
Drug: Cimetidine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (400 mg t.i.d.)
Trial: 6496286
Drug: Verapamil (453
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (453 ± 75 mg per day) + Isosorbide dinitrate (117 ± 63 mg per day)
Trial: 6496286
Drug: Nifedipine (71
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (71 ± 14 mg per day) + Isosorbide dinitrate (117 ± 63 mg per day)
Trial: 6496286
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (117 ± 63 mg per day) alone
Trial: 29902299
Drug: Dual HER2-targeted
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dual HER2-targeted therapy (lapatinib and trastuzumab)
Trial: 27357281
Drug: Cerebrospinal fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebrospinal fluid (CSF) neopterin levels in delirium patients (median 29.6 nmol/mL)
Trial: 27357281
Drug: Serum neopterin
RxNorm normalized name: Neopterin
DrugBank: Neopterin (DB15050)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum neopterin levels in delirium patients (median 37.0 nmol/mL)
Trial: 22999380
Drug: Community reinforcement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community reinforcement approach (CRA) treatment
Trial: 20459475
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract (GTE) - 572.8 mg tea catechins (TC) daily
Trial: 20459475
Drug: Placebo (PLA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PLA) - 0 mg tea catechins (TC) daily
Trial: 16820802
Drug: Standard sodium
RxNorm normalized name: Stangard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard sodium fluoride dentifrice (treatment period 1)
Trial: 16820802
Drug: Standard sodium
RxNorm normalized name: Stangard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard sodium fluoride dentifrice (treatment period 2)
Trial: 16820802
Drug: Antimicrobial stannous
RxNorm normalized name: Stannous chloride
DrugBank: Stannous chloride (DB11056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial stannous fluoride/sodium hexametaphosphate dentifrice (treatment period 3)
Trial: 10763941
Drug: Rabeprazole 20
RxNorm normalized name: RABEprazole 20 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 20 mg q.a.m.
Trial: 3119287
Drug: Six capsules
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Six capsules (Norplant)
Trial: 30305280
Drug: Eltrombopag (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eltrombopag (200 mg/d, max 300 mg/d for East Asians) plus azacitidine (75 mg/m2 subcutaneously once daily for 7 days every 28 days)
Trial: 30305280
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus azacitidine (75 mg/m2 subcutaneously once daily for 7 days every 28 days)
Trial: 26528941
Drug: Atropine sulfate
RxNorm normalized name: Atropine Sulfate
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine sulfate (0.02 mg/kg)
Trial: 25180479
Drug: Hypoenergetic diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypoenergetic diet rich in ALA (3.4 g/d)
Trial: 25180479
Drug: Hypoenergetic diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypoenergetic diet low in ALA (0.9 g/d, control)
Trial: 16037757
Drug: Topical vaginal
RxNorm normalized name: emollients, topical vaginal gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical vaginal estrogen therapy (ET group)
Trial: 8049820
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D (1,000 IU/d), Calcium (1 g/d), EHDP (7.5 mg/kg body weight)
Trial: 2838923
Drug: Kabi 2165
RxNorm normalized name: immunoglobulin G, human Injectable Solution [Kabiglobulin]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kabi 2165 (2,500 anti-Xa units once daily)
Trial: 2838923
Drug: Calcium heparin
RxNorm normalized name: HEPARIN CALCIUM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium heparin (5,000 IU twice daily)
Trial: 28472415
Drug: Acupressure treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupressure treatment (15 min, 4 times a week for 12 weeks)
Trial: 15600379
Drug: SSRIs (fluoxetine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SSRIs (fluoxetine, paroxetine, sertraline, citalopram)
Trial: 11327200
Drug: tolterodine ER
RxNorm normalized name: tolterodine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tolterodine ER 4mg once daily
Trial: 11327200
Drug: tolterodine IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tolterodine IR 2mg twice daily
Trial: 9387134
Drug: Oral protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral protein load (2 g/kg of protein as beefsteak)
Trial: 9387134
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (GFR 112 +/- 3 ml/min x 1.73 m2)
Trial: 9387134
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (GFR 68 +/- 3.2 ml/min x 1.73 m2)
Trial: 9387134
Drug: Group C
RxNorm normalized name: STREPTOCOCCUS ANTIGEN (GROUP C)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C (GFR 40.7 +/- 3.3 ml/min x 1.73 m2)
Trial: 7968283
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of ferric ammonium citrate
Trial: 10394873
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg of ferric ammonium citrate
Trial: 7968283
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of parasympathetic blockers
Trial: 2737270
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg prednisolone
Trial: 21174921
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg prednisolone
Trial: 24298767
Drug: Electroacupuncture +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture + Acupoint Injection (EA + AI)
Trial: 22649136
Drug: Low-dose involved-field
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose involved-field radiation therapy (IFRT)
Trial: 2832549
Drug: No further
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No further therapy (control)
Trial: 3280128
Drug: Haloperidol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (2.5 mg)
Trial: 11263519
Drug: Full-dose regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-dose regimen of isoniazid, rifampicin, pyrazinamide and ethambutol (Group II, n = 25)
Trial: 8027221
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg YM175
Trial: 8027221
Drug: Lower doses
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower doses of YM175
Trial: 30986790
Drug: CYD‐TDV (Dengvaxia)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CYD‐TDV (Dengvaxia) booster dose
Trial: 28494809
Drug: Physical exercise
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical exercise and dietary therapy (PED-t) for 16 weeks
Trial: 28494809
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy (CBT) for 16 weeks
Trial: 24399727
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose metformin (3 g daily in three divided doses)
Trial: 17679042
Drug: Olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil 40 mg
Trial: 16956341
Drug: Inosiplex, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inosiplex, 50 mg/kg daily per os for 12 weeks